Medical product development is a complex, expensive, risky venture. How does one get from early findings to an approved product? How do you get to the key milestones as rapidly and efficiently as possible?
Based upon decades of successful product development experience, PharmaLogic Development, Inc., can help you develop and execute a strategic plan for your product. Working in manifold therapeutic areas with pharmaceuticals, biologics and devices, our expertise is in local therapy (ophthalmology and dermatology).
Dr. Novack states “The more I work in the development of new pharmaceuticals, the more I see that early development is a complex interaction of pharmaceutics (formulation), safety assessment (local and systemic), and clinical planning. Not only do we help plan and execute what needs to be done, but what needs to be done when.”
Many of his experiences and unique perspectives in product development may be found in the over two dozen editorials he has written as a contributing editor to The Ocular Surface.
Dr. Gary Novack was recently quoted in The New York Times and featured by UC Davis Health for his expert perspective on a nationwide recall of prescription eye drops. As a nationally recognized expert in ophthalmic drug development, clinical research, and regulatory science, Dr. Novack provided insight into the importance of quality standards, manufacturing
Dr. Novack presented multiple sessions at Napa Eye 2026, including research on novel ophthalmic medications and a lecture on FDA marketing authorization for ophthalmic drugs and devices.
Dr. Gary Novack attended the 2026 ARVO Annual Meeting in Denver, continuing a tradition of more than 40 years participating in one of ophthalmology’s leading scientific conferences. During the meeting, he presented research on FDA review times and a novel investigational treatment for pterygia while connecting with colleagues and collaborators in vision science.